Literature DB >> 4753689

Accidental intravenous injection of bupivacaine: a complication of obstetrical epidural anaesthesia. Case report.

D W Ryan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4753689     DOI: 10.1093/bja/45.8.907

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  8 in total

1.  Epinephrine test dose is not warranted for confirmation of intravascular migration of epidural catheter in a parturient.

Authors:  S F Seidman; G F Marx
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

2.  A simple solution to blood clot obstruction opepidural cathétér during labour.

Authors:  Shaul Cohen; David Amar
Journal:  Can J Anaesth       Date:  1990-01       Impact factor: 5.063

Review 3.  Intraspinal opioids: implications for monitoring. Monitoring in the intensive care unit is essential.

Authors:  R F LaPorta; M D Johnson
Journal:  J Clin Monit       Date:  1989-07

4.  Etidocaine: an evaluation in epidural analgesia for obstetrics.

Authors:  P R Bromage; S Datta; L A Dunford
Journal:  Can Anaesth Soc J       Date:  1974-11

5.  Plasma concentrations of bupivacaine after wound infiltration of an 0.5% solution after inguinal herniorrhaphy: a preliminary study.

Authors:  H Kastrissios; E J Triggs; F Sinclair; P Moran; M Smithers
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Securing epidural catheters.

Authors:  B L Duffy
Journal:  Can Anaesth Soc J       Date:  1982-11

7.  Intrapleural analgesia for post-thoracotomy pain and blood levels of bupivacaine following intrapleural injection.

Authors:  J R Kambam; J Hammon; W C Parris; F M Lupinetti
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

8.  The disposition of bupivacaine following a 72 h interpleural infusion in cholecystectomy patients.

Authors:  H Kastrissios; E J Triggs; G A Mogg; J W Higbie
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.